Arrowhead Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1989-01-01
- Employees
- 525
- Market Cap
- $2.9B
- Introduction
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
Safety and Tolerability Study of ARC-520 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: ARC-520Drug: Placebo
- First Posted Date
- 2013-06-07
- Last Posted Date
- 2014-12-10
- Lead Sponsor
- Arrowhead Pharmaceuticals
- Target Recruit Count
- 54
- Registration Number
- NCT01872065
- Locations
- 🇦🇺
Nucleus Network Ltd., Melbourne, Victoria, Australia
© Copyright 2025. All Rights Reserved by MedPath